Drug intelligence / Profile preview

[18F]PLX5622

Development stage
Preclinical
Lead developer
University of Michigan
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

[18F]PLX5622 is a fluorine-18 labeled small molecule radiotracer developed by researchers at the University of Michigan for positron emission tomography (PET) imaging of the colony-stimulating factor 1 receptor (CSF1R). CSF1R is a tyrosine kinase receptor exclusively expressed on microglia in the brain and is robustly upregulated in neuroinflammatory conditions, such as Alzheimer's disease and related dementias. Derived from the highly selective, brain-penetrant CSF1R inhibitor PLX5622 (originally developed by Plexxikon), [18F]PLX5622 is synthesized via copper-mediated radiofluorination of a boronate precursor. It is designed to provide a next-generation PET imaging tool with high specific binding, enabling the non-invasive monitoring and quantification of microglial-specific neuroinflammation in vivo.

Other names
18F-PLX-562218F-PLX5622[18F]PLX-5622
02

Targets

CSF1R (Macrophage colony-stimulating factor receptor)

Beyond the preview

Go deeper on [18F]PLX5622.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]PLX5622.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call